Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,470
datasets available to search
ShareScore release 0.9.0
Dataset results
2,470 results for “Acute myeloid leukemia”
Busulfan and Etoposide Followed by Peripheral Blood Stem Cell Transplant and Low-Dose Aldesleukin in Treating Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00003875. IPD Sharing: NO. Countries: 1. Publications: 1.
Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes
ClinicalTrials.gov study NCT00369317. IPD Sharing: Not stated. Countries: 4. Publications: 1.
Study of Magrolimab Versus Placebo in Combination With Venetoclax and Azacitidine in Participants With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT05079230. IPD Sharing: NO. Countries: 20. Publications: 2.
APR-246 in Combination With Azacitidine for TP53 Mutated AML (Acute Myeloid Leukemia) or MDS (Myelodysplastic Syndromes) Following Allogeneic Stem Cell Transplant
ClinicalTrials.gov study NCT03931291. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02085408. IPD Sharing: YES. Countries: 3. Publications: 0.
Pembrolizumab and Decitabine for Refractory or Relapsed Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02996474. IPD Sharing: Not stated. Countries: 1. Publications: 1.
DS-1594b With or Without Azacitidine, Venetoclax, or Mini-HCVD for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT04752163. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of LY2181308 Sodium in Patients With Relapsed or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00620321. IPD Sharing: YES. Countries: 1. Publications: 1.
Phase 2 Study of Temozolomide to Treat Poor Risk / Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00611247. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Clofarabine, Cytarabine, and G-CSF in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00602225. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Daunorubicin & Cytarabine +/- Zosuquidar inTreating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or Refractory Anemia
ClinicalTrials.gov study NCT00046930. IPD Sharing: Not stated. Countries: 2. Publications: 2.
A Study of Venetoclax in Combination With Low Dose Cytarabine Versus Low Dose Cytarabine Alone in Treatment Naive Patients With Acute Myeloid Leukemia Who Are Ineligible for Intensive Chemotherapy
ClinicalTrials.gov study NCT03069352. IPD Sharing: YES. Countries: 24. Publications: 4.
A Study to Investigate Use of Off-the-shelf Natural Killer (NK) Cells (SAR445419) in Relapsed/Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT05712278. IPD Sharing: YES. Countries: 1. Publications: 0.
Onvansertib in Combination With Either Low-dose Cytarabine or Decitabine in Adult Patients With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT03303339. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Efficacy of Oral Azacitidine Plus Best Supportive Care as Maintenance Therapy in Subjects With Acute Myeloid Leukemia (AML) in Complete Remission
ClinicalTrials.gov study NCT01757535. IPD Sharing: Not stated. Countries: 23. Publications: 8.
A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia
ClinicalTrials.gov study NCT01440374. IPD Sharing: Not stated. Countries: 22. Publications: 2.
Study to Investigate the Safety and Clinical Activity of GSK3326595 and Other Agents to Treat Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT03614728. IPD Sharing: YES. Countries: 2. Publications: 1.
Peginterferon Alfa-2a to Enhance Anti-leukemic Responses After Allogeneic Transplantation in Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02328755. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Reduced Intensity Donor Peripheral Blood Stem Cell Transplant in Treating Patients With De Novo or Secondary Acute Myeloid Leukemia in Remission
ClinicalTrials.gov study NCT00045435. IPD Sharing: Not stated. Countries: 1. Publications: 1.
DT388IL3 Fusion Protein in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes
ClinicalTrials.gov study NCT00397579. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.